Aristopharma Ltd. is pleased to introduce Asmalin Plus, a Salbutamol + Budesonide HFA inhaler and the first US FDA-approved combination rescue medication for Asthma attacks. It provides rapid bronchodilation with Salbutamol and early anti-inflammatory action with Budesonide, in line with the latest GINA guideline recommendations for acute Asthma exacerbations—offering a modern and effective rescue treatment.
FR
DE